Adalimumab Therapy for Recalcitrant Pyoderma Gangrenosum

Objective: To describe a patient with treatment-refractory pyoderma gangrenosum and the outcome of a novel therapeutic approach. Methods: Case report and review of the literature. Results: A patient with inflammatory bowel disease developed severe pyoderma gangrenosum while receiving treatment with...

Descripción completa

Detalles Bibliográficos
Autores principales: Fonder, Margaret A., Cummins, Deborah L., Ehst, Benjamin D., Anhalt, Grant J., Meyerle, Jon H.
Formato: Texto
Lenguaje:English
Publicado: Open Science Company, LLC 2006
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1687150/
https://www.ncbi.nlm.nih.gov/pubmed/17149453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1687150/
https://www.ncbi.nlm.nih.gov/pubmed/17149453

Ejemplares similares